NOMAD POWER SOLUTIONS, INC. Foreign Currency Transaction Gain (Loss), Realized
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Foreign Currency Transaction Gain (Loss), Realized of $4.14 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2026-08-14
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), realized for the quarter ending 2026-06-30 was $4.14K, a 612.74% increase year-over-year.
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), realized for the quarter ending 2026-03-31 was -$475.00, a 701.27% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), realized for the quarter ending 2025-12-31 was -$5.00.
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), realized for the quarter ending 2025-09-30 was -$130.00.
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), realized for fiscal 2025 was $525.00.
- NOMAD POWER SOLUTIONS, INC. foreign currency transaction gain (loss), realized for fiscal 2024 was -$3.40K.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.14K 10-Q · filed 2026-08-14 | $3.67K 10-Q · filed 2026-08-14 | $3.66K derived: sum of 3 quarters · filed 2026-08-14 | $3.53K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$475.00 10-Q · filed 2026-05-14 | -$480.00 derived: sum of 2 quarters · filed 2026-05-14 | -$610.00 derived: sum of 3 quarters · filed 2026-05-14 | -$29.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$5.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$135.00 derived: sum of 2 quarters · filed 2026-03-31 | $446.00 derived: sum of 3 quarters · filed 2026-08-14 | $525.00 10-K · filed 2026-03-31 |
| 2025-09-30 | -$130.00 10-Q · filed 2025-11-12 | $451.00 derived: sum of 2 quarters · filed 2026-08-14 | $530.00 10-Q · filed 2025-11-12 | $246.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $581.00 10-Q · filed 2026-08-14 | $660.00 10-Q · filed 2026-08-14 | $376.00 derived: sum of 3 quarters · filed 2026-08-14 | -$2.79K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $79.00 10-Q · filed 2026-05-14 | -$205.00 derived: sum of 2 quarters · filed 2026-05-14 | -$3.37K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$284.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$3.44K derived: sum of 2 quarters · filed 2026-03-31 | -$3.40K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$3.16K 10-Q · filed 2025-11-12 | -$3.12K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |